Member Info for Laura2022

Returning

Great to see

Well done and congratulations

THRU potential premium takeover as they are up for sale

Grey trades look like a transfer

The Company is actively discussing a number of further contracts although there is no guarantee they will be signed within the current financial year.

Trench, you ARE right

They've been testing it for last 7mths..maybe more as per the update above

June 2024

today’s announcement of the plan to launch Physiomics’ dosing software on the recently upgraded and expanded DoseMeRx platform and to make it available, initially on a research basis, to selected US clients. It is expected that the software will be made available in the second half of 2024.

The two companies have also agreed to identify one or more centers in the US, currently served by DoseMe, that have historical patient data that could be used to further develop Physiomics’ dosing software and specifically to enhance its ability to support decision making around the use of the expensive biological drug GCSF which is commonly used by clinicians to counteract the neutropenic tendency of chemotherapeutic agents.

Moving Forwards

The focus of Physiomics’ personalised dosing initiatives going forwards will be to expand the capability of the software to support dosing decision making around not only chemotherapeutic agents but GCSF. Both the ongoing PREDICT-ONC study and potential secondary research with DoseMe clients in the US will support this objective.

Https://doseme-rx.com/en-gb/news-media/article/physiomics-adds-functionality-to-doseme

You'll also notice alot of people have gone quiet last 7 days so presumably we're just traders

Importantly the Tr1 8% holder may well choose to add possibly

Thanks Trench

Certainly the dosing tool would be very close to roll out given the timeliness given in the June 2024 DoseMeRx/PYC joint update

Castle

Stocks like FAB PYC and many others have had great rises and natural retracts

Eg FAB 10p to 7.8p

PYC 1.1p to 0 85p

It's all part and parcel + general Trump tariff market gloom

?

Vindicates buying back 3 weeks ago

He's a petulant child

Does he think anyone cares about his lame excuses

Fonzi

Interesting developments THRU GTC

Fantastic Basil

Thankyou

Basil and Andy

Nice information thanks

Ignore Jaari888..he's a pain

News released on one of them Hopist

The annual recurring revneus is nearly £3mln , against a market value of £3mlnand now with zero debt

A few more contracts from the £4mln order book and more RR and this bevies very undervalued

Something not lost on the 10% TR1 stake builder

Camp

You will know better than me but today suggests all borrowing sorted and cash flownpositve could be achieved later in 2025

"thereby eliminating all Company borrowings and significantly improving the Company's financial position."

This is his 4th ID in as many weeks and plastered ENET on 10 bulletin board!!